Najjar I, Fagard R
Biochimie. 2010; 92(5):425-44.
PMID: 20159032
PMC: 7117016.
DOI: 10.1016/j.biochi.2010.02.009.
Elliott S, Suhrbier A, Miles J, Lawrence G, Pye S, Le T
J Virol. 2007; 82(3):1448-57.
PMID: 18032491
PMC: 2224445.
DOI: 10.1128/JVI.01409-07.
Khanna R, Bell S, Sherritt M, Galbraith A, Burrows S, Rafter L
Proc Natl Acad Sci U S A. 1999; 96(18):10391-6.
PMID: 10468618
PMC: 17898.
DOI: 10.1073/pnas.96.18.10391.
Highton J, Panayi G
Ann Rheum Dis. 1980; 39(6):559-62.
PMID: 7458432
PMC: 1000620.
DOI: 10.1136/ard.39.6.559.
North J, Morgan A, Thompson J, Epstein M
Proc Natl Acad Sci U S A. 1982; 79(23):7504-8.
PMID: 6296836
PMC: 347368.
DOI: 10.1073/pnas.79.23.7504.
Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.
Takada K, OSATO T
Med Microbiol Immunol. 1981; 170(1):19-26.
PMID: 6272076
DOI: 10.1007/BF02123793.
Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis.
Sculley T, Walker P, Moss D, Pope J
J Virol. 1984; 52(1):88-93.
PMID: 6090712
PMC: 254493.
DOI: 10.1128/JVI.52.1.88-93.1984.
Serological studies of HL-A on continuous lymphoblastoid cell lines (CLC) and the definition of an antigen on CLC determined by a heat-labile antibody.
Dumble L, JACK I, Morris P
Clin Exp Immunol. 1974; 17(3):441-54.
PMID: 4466611
PMC: 1554084.
Inhibition of lymphocyte motility by interleukin 2.
Hoon D, Wen D, Stene M, Gupta R, Cochran A
Clin Exp Immunol. 1986; 66(3):566-73.
PMID: 3105935
PMC: 1542478.
Induction of Epstein-Barr virus nuclear antigens.
Moss D, Sculley T, Pope J
J Virol. 1986; 58(3):988-90.
PMID: 3084809
PMC: 253013.
DOI: 10.1128/JVI.58.3.988-990.1986.
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J, Rowe M, Kallin B, Ernberg I, Rosen A, Dillner J
J Virol. 1987; 61(12):3870-8.
PMID: 2824821
PMC: 256005.
DOI: 10.1128/JVI.61.12.3870-3878.1987.
Variations in lymphokine generation by individual lymph nodes draining human malignant tumors.
Wen D, Hoon D, Chang C, Cochran A
Cancer Immunol Immunother. 1989; 30(5):277-82.
PMID: 2696592
PMC: 11041092.
DOI: 10.1007/BF01744894.
Reactivity of antibody in acute myeloid leukaemia with proliferation-associated nuclear antigen(s).
Russell A, Pope J
Clin Exp Immunol. 1976; 23(1):83-90.
PMID: 1063068
PMC: 1538372.
Polypeptides of the Epstein-Barr virus membrane antigen complex.
Thorley-Lawson D, Edson C
J Virol. 1979; 32(2):458-67.
PMID: 228070
PMC: 353577.
DOI: 10.1128/JVI.32.2.458-467.1979.
Establishment of peripheral lymphoid cell cultures from patients with Hodgkin's disease depending on Epstein-Barr-Virus-reactivity and cellular immunity.
Diehl V, Johansson B
Blut. 1977; 34(3):227-36.
PMID: 191123
DOI: 10.1007/BF00996173.
Inhibition of EB virus transformation of non-adherent human lymphocytes by co-cultivation with adult fibroblasts.
Moss D, Pope J, Scott W
Med Microbiol Immunol. 1976; 162(3-4):159-67.
PMID: 187915
DOI: 10.1007/BF02120993.
Epidemiological studies of Epstein-Barr herpesvirus infection in Western Australia.
Lai P, MACKAY-SCOLLAY E, Alpers M
J Hyg (Lond). 1975; 74(3):329-37.
PMID: 168249
PMC: 2130598.
DOI: 10.1017/s0022172400046842.
Abortive growth of human lymphocytes carrying a dormant Epstein-Barr viral genome.
Aya T, OSATO T
Med Microbiol Immunol. 1978; 164(4):255-66.
PMID: 45600
DOI: 10.1007/BF02125494.
